CD24 and neoplasm: We discuss our findings on the anti-tumor mechanism of IMM47, a humanized monoclonal antibody (mAb) targeting CD24, which inhibits CD24/Siglec-10 interaction via macrophage antigen presentation while increasing NK cell cytokine release.